Page last updated: 2024-11-02

pirenzepine and Pervasive Child Development Disorders

pirenzepine has been researched along with Pervasive Child Development Disorders in 8 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Research Excerpts

ExcerptRelevanceReference
"The findings suggest that olanzapine is a promising treatment for children with autistic disorder."9.09Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. ( Cater, J; Choudhury, MS; Delaney, MA; Malone, RP; Sheikh, RM, 2001)
"The findings suggest that olanzapine is a promising treatment for children with autistic disorder."5.09Olanzapine versus haloperidol in children with autistic disorder: an open pilot study. ( Cater, J; Choudhury, MS; Delaney, MA; Malone, RP; Sheikh, RM, 2001)
"The most convincing evidence of the efficacy of atypical neuroleptics in children and adolescents concerns clozapine in the treatment of schizophrenia."4.80Use of atypical neuroleptics in child and adolescent psychiatry. ( Laor, N; Toren, P; Weizman, A, 1998)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's5 (62.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kemner, C1
Willemsen-Swinkels, SH1
de Jonge, M1
Tuynman-Qua, H1
van Engeland, H1
Horrigan, JP1
Barnhill, LJ1
Courvoisie, HE1
Toren, P1
Laor, N1
Weizman, A1
Potenza, MN2
Holmes, JP1
Kanes, SJ1
McDougle, CJ2
Demb, HB1
Roychoudhury, K1
Malone, RP1
Cater, J1
Sheikh, RM1
Choudhury, MS1
Delaney, MA1
Buckley, PF1

Reviews

2 reviews available for pirenzepine and Pervasive Child Development Disorders

ArticleYear
Use of atypical neuroleptics in child and adolescent psychiatry.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12

    Topics: Adolescent; Adult; Age Factors; Antipsychotic Agents; Benzodiazepines; Child; Child Development Diso

1998
Broad therapeutic uses of atypical antipsychotic medications.
    Biological psychiatry, 2001, Dec-01, Volume: 50, Issue:11

    Topics: Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child Development Disorders, P

2001

Trials

2 trials available for pirenzepine and Pervasive Child Development Disorders

ArticleYear
Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study.
    Journal of clinical psychopharmacology, 1999, Volume: 19, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Child; Child Develop

1999
Olanzapine versus haloperidol in children with autistic disorder: an open pilot study.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2001, Volume: 40, Issue:8

    Topics: Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Child; Child Development Disorders, Pervas

2001

Other Studies

4 other studies available for pirenzepine and Pervasive Child Development Disorders

ArticleYear
Open-label study of olanzapine in children with pervasive developmental disorder.
    Journal of clinical psychopharmacology, 2002, Volume: 22, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Benzodiazepines; Child; Child Development Disor

2002
Olanzapine in PDD.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1997, Volume: 36, Issue:9

    Topics: Antipsychotic Agents; Benzodiazepines; Child; Child Development Disorders, Pervasive; Humans; Male;

1997
Comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study".
    Journal of clinical psychopharmacology, 2000, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Child; Child Development Disorders, Pervas

2000
Reply to comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study".
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:2

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Child; Child Development Disorders, Pervas

2001